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Multiple coronary vasospasm: a cause of
repeated myocardial infarction and
symptomatic 'torsade de pointes'
(atypical ventricular tachycardia)
A case presentation and review
J. z. PRZYBOJEWSKI
Summary
A middle-aged Coloured man had a 6-year history
of chest pain induced by effort and also experienced
at rest. Quite dramatic episodes of associated
arrhythmias, specifically 'torsade de pointes' (aty-
pical ventricular tachycardia) and syncope were
experienced by the patient, despite the use of
numerous anti-arrhythmic and anti-anginal agents.
Transmural anteroseptaI and non-transmural.
anterolateral myocardial infarctions were docu-
mented in the presence of a normal left coronary
artery (LCA). Severe reversible vasospasm of the
right coronary artery (RCA) was provoked with the
use of ergonovine (ergometrine) maleate at cardiac
catheterization. It is postulated that the cause of the
previous myocardial infarctions was significant
vasospasm of the LCA branches, and that he was
subject to multiple coronary vasospasm, as was
highlighted by the visualization of spasm superim-
posed on atheromatous plaque within the RCA.
Furthermore, it is strongly suggested that the poten-
tially lethal ventricular arrhythmias, inclUding 'tor-
sade de pointes', were a direct result of coronary
vasospasm L which in turn gave rise to his presyn-
cope and syncope attacks. No evidence of sino-
atrial node disease could be found.
The only risk factor for ischaemic heart disease
which applied in his case was heavy cigarette smo-
king. Control of his disabling symptoms seems to
have been achieved by' the use of maintenance
nifedipine (a calcium-blocking agent), long-acting
nitrates (isosorbide dinitrate) and quinidine gluco-
nate, confirming the probable vasospastic aetiology
of the 'torsade de pointes'. At no stage was there
dangerous prolongation of the QT interval, an oft-
quoted prerequisite for this·arrhythmia. •
Some of the more important aspects of coronary
vasospasm are discussed; as far as I am aware this is
the first patient documented in the liter<:jture with
'torsade de pointes' associated with angiographi-
cally demonstrated coronary artery spasm.
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Clinical presentation
The patient was a 57-year-old Coloured man who was initially
admitted to the Coronary Care Unit of Tygerberg Hospital,
Parowvallei, CP, in January 1976 with a few months' history of
retrosternal pain on effon as well as at rest, and occasional
dizziness related to physical exertion. At that stage an ECG (Fig.
la) showed evidence of a possible old transmural anteroseptal
myocardial infarction. The possibility of essential hypertension
was considered (a blood pressure reading of 170/100 mmHg was
recorded), and he was given propranolol and methyldopa, as well
as sublingual isosorbide dinitrate when required. Later that year
he complained of dyspepsia; barium studies were all negative.
Fig. 1. a - ECG showing a possible old transmural anteroseptal
myocardial infarction; b - ECG taken some 4 years later, show-
ing no significant change.
I first saw the patient in October 1977 when he was admitted
to the Coronary Care Unit of Tygerberg Hospital. His history
was that of severe chest pain occurring at rest. Serial electrocar-
diographic and enzyme studies documented a non-transmural,
anterolateral acute myocardial infarction (AMI). Clinical exa-
mination revealed no abnormal features apan from an apical
grade 1/6 systolic murmur which did not alter with the Valsalva
manoeuvre or with the patient squatting. The possibility of
hypertrophic obstructive cardiomyopathy or mitral valve pro-
lapse was considered, but this was not substantiated by normal
echocardiographic fmdings. The patient was discharged without
complications of the infarction and was advised to stop smoking
(he had been smoking some 40 cigarettes daily for many years).
Other possible risk factors such as hyperlipoproteinaemia and
diabetes mellitus 'were excluded by appropriate investigations.
There was no family history of heart disease.
The patient continued experiencing angina on effon despite
receiving maintenance propranolol and sublingual isosorbide
dinitrate. In addition, he complained ofseveral episodes of palpi-
tations related to effort, which were followed by angina and then
by dizziness and syncope. Holter monitoring revealed numerous
multifocal ventricular extrasystoles (only related to his symptom
of angina), ventricular bigeminy and trigeminy, but no evidence
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Fig. 2. Holter electrocardiographic tracings (modified standard
lead 11): a - multi focal ventricular extrasystoles, ventricular
bigeminy and trigeminy is visualized; b - 'torsade de pointes'
(atypical ventricular tachycardia); c - most recent study, show-
ing normal sinus rhythm.
of ventricular tachycardia or fibrillation (Fig. 2a). No supraven-
tricular arrhythmias were recorded, bur some 2 mm ofhorizontal
ST-segment depression was noted during episodes of angina
(Fig. 3).
A submaximal treadmill stress test induced no signs of
ischaemia or any ventricular tachycardia or fibrillation. The
patient was successfully treated with mexiletine and quinidine,
and the dosage of R-blocker was increased. However, he con-
tinued to experience effort angina and presyncope. The onset of
frequent angina at rest and severe head injuries secondary to _
syncope prompted' readmission in September 1979. Repeated
electro-encephalographic recordings were unremarkable and
neurological assessment was negative.
He was an exceptionally well-built, tall man with no evidence
of hypertension or valvular heart disease. A chest radiograph was
NO ANGINA
SEvERE ANGINA
Fig. 3. Holter electrocardiographic tracings (modified standard
lead 11). Several unifocal ventricular extrasystoles are seen; sig-
nificant (2 mm) horizontal ST-segment depression (arrowed) is
present during severe angina.
entirely normal and a resting ECG (Fig. Ib) showed similar
features to those of the ECG recorded in January 1976. The
biochemical and haematological values were all within normal
limits. M-mode echocardiography was again negative.
The patient continued to experience unstable angina and it
was therefore decided to carry our cardiac catheterization.and
selective coronary angiography. The procedure documented
normal intracardiac pressures and parameters of left ventricular
function. Left ventricular cine angiography (Fig. 4) identified a
normally contracting chamber with a definite area ofanterobasal
dyskinesia secondary to myocardial infarction. There was no
evidence of mitral valve prolapse, mitral insufficiency, calcifica-
tion or hypertrophic cardiomyopathy. The right coronary artery
(RCA) was dominant and displayed no obstructive lesions (Fig.
5). Likewise, the left coronary artery (LCA) was also seen to be
normal on angiography (Fig. 6). The patient was therefore diag-
nosed as having 'angina pectoris with normal coronary arteries'.
Ergonovine provocation was not carried our at this stage. Treat-
ment with the calcium-blocking agent nifedipine was com-
menced, in addition to high dosage isosorbide dinitrate and
quinidine gluconate. Propranolol was discontinued since coro-
nary vasospasm was considered likely.
The patient was followed up regularly on an ourpatient basis at
the Cardiac Clinic ofTygerberg Hospital. He continued to com-
plain of episodes oflong-Iasting, atypical and cyclical precordial
pain at rest, which were poorly relieved by sublingual isosorbide
dinitrate. In addition, he experienced bitemporal headaches
associated with visual disturbance and nausea. These attacks
were most suggestive of migraine. Several Holter monitoring
sessions failed to document ventricular tachycardia or fibrilla-
tion. Furthermore, a possible 'sick sinus syndrome' could not be
demonstrated. It was then decided to add sotalol hydrochloride
to his calcium-blocker therapy in view of its additional class III
anti-arrhythmic action. The quinidine gluconate and mexiletine
were discontinued. Repeated neurological assessment revealed
no abnormality, there being no sign of temporal lobe epilepsy in
particular. Repeat barium studies of the upper gastro-intestinal
tract were negative and the cervical spine was normal. His ECG
reading remained unchanged from that taken in 1979.
The patient's symptoms then improved quite drastically, so
much so that he was able to return to his work as a welder;
however, this proved to be only a temporary relief. In January
1982 he was seen in the casualty department with severe facial
injury secondary to syncope preceded by a peculiar epigastric
sensation, palpitations and a crushing retrosternal pain. Again, a
resting ECG was unchanged-from previous tracings. He was
then admined to the Cardiac Unit for observation and Holter
monitoring. On this occasion repeated Holter examinations
revealed long episodes of ventricular bigeminy, trigeminy, com-
plex ventricular extrasystolic activity, ventricular tachycardia
and 'corsade de poinres' (atypical ventricular tachycardia) (Fig.
2b). Supraventricular arrhythmias were also documented. The
dosage of sotalol was increased and that of nifedipine continued.
He had no syncope while hospitalized for a period of several
weeks, and repeat M-mode echocardiograms were again normal.
The patient was discharged, only to be readmitted within a few
weeks with unstable angina pectoris, presyncope and syncope.
All medication was then discontinued, apart from the frequently
a
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administered sublingual isosorbide dinitrate. Repeated serial
enzyme estimations and resting ECGs were all within normal
limits. 'Ventricular ectopic activity also appeared to have
regressed. Submaximal treadmill stress testing was repeated but
this failed to show any ischaemia or provoke ventricular
arrhythmias. A thallium-20 I exercise test was then performed,
but this did not reveal fearures positive for myocardial ischaemia.
b
RAO RAO
Fig. 4. left ventricular cine angiograms demonstrating area of anterobasal dyskinesia (arrowed) due to previous myocardial
infarction: a - right anterior oblique (RAO) view with left ventricle in end-diastole (lVED); b-RAO view with left ventricle in
end-systole (lVES).
a
LAO
b
RAO
Fig. 5. Right coronary cine angiograms in the (a) left anterior oblique (LAO) and (b) RAO views. The artery is dominant and there are
no visible lesions.
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Because no adequate explanation was found for the symptoms
and coronary vasospasm seemed a likely pathophy iological
mechanism, it wa decided to undertake repeat cardiac catheteri-
zation, selective coronary angiography and ergonovine provoca-
tion. All the intracardiac pressures and indices ofleft ventricular
contractility were normal. Left ventricular cine angiography in
the RAO projection still demonstrated the anreroba al dyskine-
sia shown previously, but no other abnormalities (Fig. 7). Base-
line selective coronary angiography in multiple projections deh-
a
neated a dominant RCA with a minor intemalluminal irregularity
in its econd part (Fig. 8). This lesion was calculated as a 42%
diameter stenosis and 67% area stenosis (Tahle I). The LCA
appeared normal on angiography (Fig. 9). The patient did not
complain of chest pain during the injections and there were no
electrocardiographic changes in standard lead II and lead VS on
the oscilloscope. A l2-lead ECG was no different from the
previously recorded tracings. The ergonovine provocation test
wa then carried out bv the iniection of an initial bolus of 0.02')
b
LAO RAO
Fig. 6. Left coronary cine angiograms in the (a) LAO and (b) RAO projections, demonstrating normal vessels.
a b
RAO RAO
Fig. 7. Left ventricular angiograms demonstrating area of anterobasal dyskinesia (arrowed) due to past myocardial infarction. a-
RAO view with LVED; b - RAO view with LVES.
mg into the main pulmonary artery while monitoring the aortic
pres ure and standard lead 11 and lead VS on the oscilloscope. In
addition, a 12-lead ECG was recorded every minute. A further
bolus of 0,025 mg was given after a period of 4 minutes and the
monitoring procedure repeated. Boluses of 0,05 mg were then
administered to a total dosage of 0,4 mg of ergonovine maleate.
The RCA was then opacified with contrast medium in the
LAO view, at which stage a severe, long-segment (7 mm) con-
striction was noted in the area previously delineated by an insig-
nificant narrowing (Fig. lOa); this was calculated as causing an
a
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80% diameter stenosis and 96% area stenosis (Table I). At this
stage the patient complained of severe retrosternal pain accom-
panied by marked ST-segment elevation noted in standard lead
11 on the oscilloscope (unfortunately unrecorded). The patient
was promptly given sublingual isosorbide dinitrate 5 mg and
repeated right coronary cine angiogram were taken in the LAO
projection (Fig. lOb). His chest pain subsided quite rapidly with
return of the ST segment to the iso-electric line. Injection of
intracoronary nitrate was not necessary, although this prepara-
tion was available. Repeat injections into the RCA demonstrated
b
LAO RAO
Fig. 8. Right coronary cine angiograms in the (a) LAO and (b) RAO views, taken before ergonovine provocation. A minor luminal
irregularity (arrowed) is shown in (a).
a b
LAO RAO
Fig. 9. Left coronary cine angiograms in the (a) LAO and (b) RAO projections, taken before ergonovine provocation. The vessels are
angiographically normal.
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TABLE I. CORONARY ANGIOGRAPHIC MEASUREMENTS
Post-ergo.
Minimum diameter (mm)
% diameter stenosis
Length of lesion (mm)
Minimum area (mm 2)
% area stenosis
Pre-ergo.
(LAO)
1,40
42
6,0
1,54
67
1(LAO)
0,52
80
7,0
0,22
96
2(LAO)
1,14
52
7,0
1,01
77
3(RAO)
1,80
25
2,0
2,55
43
4(RAO)
1,55
35
4,0
1,88
58
a
Pre-ergo. ;;;; before ergonovine: post-ergo. = after ergonovine: LAO;;;; left anterior oblIque View, AAO = right antenor oblique view: 1. 2, 3, 4
= time sequence of coronary arteriogram after ergonovine injection.
b
LAO LAO
Fig. 10. Right coronary.cine angiograms in the LAO projection immediately after ergonovine provocation. Severe vasospasm
(arrowed) is seen in (a), which is less following sublingual isosorbide dinitrate (b) (see Table I).
a progressive decrease in severity of the obstruction (Fig. lOb);
the vasoconstriction now amounted to a 52% diameter stenosis
and 77% area stenosis, measurements similar to those obtained
before the injection (Table I). The RCA in the RAO view had no
significant vasospasm (Fig. 11). Similarly, the LCA was deli-
neated.in the RAO and LAO projections and found to be angio-
graphically normal (Fig. 12). There were no further episodes of
chest pain and no further electrocardiographic abnormalities
could be visualized. The procedure was completed without com-
plication. On subsequent days serial serum enzyme estimations
and 12-lead ECGs showed no evidence of AMI.
A definitive diagnosis of coronary vasospasm superimposed
on a probable atheromatous lesion in the second part of the RCA
was thus established. The patient was then placed on a regimen
comprising high doses oforal nifedipine and isosorbide dinitrate.
In addition, oral quinidine gluconate 324 mg 8-hourly was
administered. Repeated Holter monitoring failed to show any
significant ST-segment elevation or depression, or any ventricu-
lar arrhythmias (Fig. 2c). The patient had no further episodes of
chest pain and was discharged. He has remained asymptomatic.
Numerous periods of Holter monitoring have documented nor-
mal sinus rhythm as well as no ischaemic ST-T-wave changes.
Discussion
The concept of coronary artery spasm in the pathogenesis of
angina pectoris is not new since it was suggested by Heberden in
1792, although he is usually remembered for having defined the
criteria for 'classic' angina pectoris, that is, effort-related chest
pain. In 1876 Latham supported the concept of coronary artery
spasm and this was later given more credibility by OsIer in 1910.
Tevertheless, following this the repeated finding of coronary
artery thrombi in patients dying ofmyocardial infarction promp-
ted support for the concept of an organic obstructive cause of
angina pectoris rather than a functional one. Thus, the concept of
coronary vasospasm lost popularity for a considerable period of
time until 1955 when Prinzmetal er al. I documented cases of
paroxysmal angina occurring at rest and associated with very
significant, reversible ST-segment elevation. They postulated
the superimposition of coronary artery spasm on atherosclerotic
narrowing, thus reintroducing the concept of a functional com-
ponent in symptomatic ischaemic heart disease as represented by
angina, AMI and sudden death. In the succeeding years the work
of such researchers as MacAlpin,2 Oliva and Breckenridge,3
Conti er al.,4 Chahine er al.,; and Maserielal. 6 firmly established
the pivotal role of coronary vasospasm, not only in the presence
of coronary atheroma but also with underlying angiographically
normal coronary arteries. The last few years have wimessed a
flood of publications concerning coronary artery spasm, the
implications of which are essential to the understanding of the
rationale of current therapeutic practice in the clinical spectrum
of ischaemic heart disease. Our ca e illustrates some of the
important aspects of coronary vasospasm. In addition, the life-
threatening arrhythmia termed 'lOrsade de poimes' appears to be
described for the first time in angiographically proven coronary
artery spasm.
a
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Atypical ventricular tachycardia
This arrhythmia was initially described by Dessertenne7 in
1966. Various synonyms have been employed, e.g. polymor-
phous ventricular tachycardia, atypical ventricular tachycardia,B
cardiac ballet,9 repetitive paroxysmal tachycardia, transient ven-
tricular fibrillation,1O and 'lOrsade de poimes '. I1 The mechanism
of this potentially fatal arrhythmia is not clearly understood, but
it i thought to be due to a re-entry mechanism secondary to
impaired ventricular repolarization. Krikler ll attempts to distin-
guish 'lOrsade de poimes' from ventricular tachycardia by stating
b
RAO RAO
Fig. 11. Right coronary cine angiograms in RAO view showing no significant vasospasm.
a
LAO
b
RAO
Fig. 12. Left coronary cine angiograms in the (a) LAO and (b) RAO projections after ergonovine provocation. No vasospasm is evident.
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that in the latter a prolonged QT interval is present, and that a
late ventricular extrasystole initiates the arrhythmia which has
the form of 'twisting complexes' due to undulation of the QRS
axis. The episodes may be short or prolonged, and a very real
danger is that of degeneration into ventricular fibrillation with
ensuing sudden death. Difficulty often arises in distinguishing
this arrhythmia from 'bidirectional ventricular tachycardia'. 12
Classically, 'corsade de poinces' has been described in the set-
ting of QT prolongation. Thus, drugs such as quinidine,IJ pro-
cainamide, lignocaine, prenylamine, disopyramide,14 mexiletine,
and amiodarone l5 have been incriminated, as have tricyclic
antidepressants and the phenothiazine .16 Electrolyte disturban-
ces such as hypokalaemia (Conn's syndrome; familial periodic
paralysis) and hypomagnesaemia are also well-known causes.
Other conditions, such as acute myocarditis, sino-atrial disease,
high-degree atrioventricular block, Jervell and Lange-Nielse':l
syndrome, and the Romano-Ward syndrome, have been asso-
ciated with this arrhythmia. In 2 cases paroxysmal atrioventricu-
lar block causing syncope was associated with 'ro/"sade de poinres'
as well as angina pectoris attributed to coronary vasospasm
(Prinzmetal's variant angina),17 but vasospasm was not docu-
mented by coronary arteriography. I was unable to find any
report in the literature of proven coronary vasospasm and 'co/"-
sade de poimes', so our case may be unique. Very rarely this
arrhythmia has complicated AMI due to asynchrony ofventricu-
lar repolarization. Atypical ventricular tachycardia, occurring
over a period of many years, has been reported in asymptomatic
people. The use of anti-arrhythmic drugs in this group of people
is uniformly ineffective, and they appear to suffer from a benign
variation of this abnormality.
I t is important to distinguish 'corsade de poinces' from conven-
tional ventricular tachycardia and idioventricular tachycardia, as
the treatment and prognosis differ. Most of the drugs used to
counteract ventricular tachycardia can cause atypical ventricular
tachycardia. Correction of electrolyte disturbances is of para-
mount importance, as well as the discontinuation of the causative
drug. Direct-current countershock may convert 'corsade de
poinres' to ventricular fibrillation. Krikler" and Krikler and
Curry l2 suggest the emergency use of intravenous isoprenaline
infusion in an attempt to shorten the period of repolarization and
thus counteract the defect of asynchronous depolarization.
Overdrive temporary transvenous cardiac pacing has been do-
cumented as life-saving, and is also indicated in the presence of
complete heart block giving rise to 'corsade de poinres. '
Electrocardiographic spectrum of coronary
vasospasm
The classic prototype ofcoronary artery spasm is Prinzmetal's
variant angina, originally described with marked temporary ST-
segment elevation (indicative of subepicardial injury) associated
wi th recurrent episodes ofatypical chest pain, often occurring at
rest. I This electrocardiographic change is manifest in transmural
myocardial ischaemia and is often secondary to total occlusion of
the involved coronary artery, the anatomical distribution of
which is accurately localized by the ECG. Less severe forms of
myocardial ischaemia due to vasospasm causing incomplete
occlusion of a coronary artery give rise to non-transmural (sub-
endocardial) myocardial ischaemia. This latter abnormality gives
rise to 'pseudonormalization' of T waves (previously inverted T
waves become upright) or transient ST-segment depression as a
result ofdistal collateral blood supply, or even vasospasm involv-
ing a small coronary artery branch. IS Non-transmural ischaemia
is often diffuse, and accurate electrocardiographic localization of
the involved coronary artery can therefore be most difficult.
More recently, coronary vasospasm has also been implicated
in effort-induced angina pectoris. 19.20 Thus, stress-testing has
shown transient ST-segment elevation which often correlates
with significant obstructions delineated by coronary arterio-
graphy. ST-segment depression occurring on exercise has also
been attributed to coronary vasospasm, and is more frequently
associated with underlying significant atherosclerotic obstruc-
tive lesions. Nevertheless, Boden ec aUI have demonstrated
exercise-induced ST-segment depression due to coronary vaso-
spasm of an angiographically normal coronary anery. This
important observation raises the exciting possibility that vaso-
spasm may well be more commonly responsible for effort-
induced angina pectoris, as well as a 'positive stress ECG'. The
concomitant use of thallium-201 in patients with coronary
vasospasm at rest and/or on exercise has more clearly localized
the area of myocardial ischaemia and the coronary artery in.vol-
ved. 1S Cases of multiple coronary artery spasm have also been
documented, but are rather rare 22
In some patients transient Q waves have been reported during
an episode of coronary vasospasm, but this electrocardiographic
feature usually signifies the presence of transmural AMI secon-
dary to vasospastic subendocardial ischaemia. The QT interval
may be prolonged during an episode of coronary artery spasm
causing variant angina. This electrophysiological abnormality
may well be important as regards the precipitation of 'corsade de
poimes' (as in our patient) and other arrhythmias, some ofwhich
may prove fatal and thus account for cases of 'sudden death'.
However, the Holter recordings of this patient failed to show any
QT prolongation before the onset of the atypical ventricular
tachycardia ('corsade de poinces') associated with episodes of
angina experienced at rest. Also, this investigation revealed sig-
nificant ST-segment depression during the angina attacks at
rest, this being indicative of non-transmural myocardial ischae-
mia secondary to 'incomplete' coronary vasospasm. This is in
contrast to the marked ST-segment elevation associated with
severe angina resulting from transient transmural myocardial
ischaemia provoked by ergonovine (ergometrine) maleate stimu-
lation. Variations in the severity of myocardial ischaemia, as
represented by the differing electrocardiographic and thallium-
20 I ('cold spot') scans, have been well documented in the same
patient at different times. IS
Aetiology and provocation of coronary
vasospasm
It has been appreciated for a long time that the epicardial
coronary arteries are innervated both by a-adrenergic and B-
adrenergic fibres. Constriction is attributed to stimulation of the
former and dilatation to the latter. Thus, B-receptor blockade
would tend to negate vasodilatation and unmask the a-receptor
vasoconstrictor action. Some researchers have stressed an actual
increase in a-adrenergic stimulation as manifested by coronary
vasospasm occurring frequently at night and in the early hours of
morning (circadian rhythm), as well as during cold weather and
rapid eye movement sleep.23 l\10re recently it has been demon-
strated that underlying coronary athecosclerosis, and probably
altered serum cholesterol levels, may augment a-mediated coro-
nary vasospasm. Intrinsic smooth-muscle contractility has been
clearly shown in the coronary arteries of explanted and dener-
vated hearts known to be dependent on calcium ion fluxes. 24 The
thromboxane A2-prostacyclin counteraction has also been consi-
dered to be important in coronary vasospasm. The former sub-
stance is released by platelets and is a potent smooth-muscle
constrictor, while the latter is synthesized by intima and is a
powerful vasodilator. Possible underlying pathophysiological
mechanisms are further complicated by the influence of pH and
blood gas tensions, alkalosis being said to provoke coronary
vasospasm since hydrogen ions directly compete with calcium
ions for entry into myocardial cells. More recently histamine has
been implicated. 25 Furthermore, Maseri ec al. 6 favour the con-
cept of ,hypersensitive' coronary smooth muscle. It would there-
fore seem highly likely that the cause of coronary vasospasm is
multifactorial.
An understanding of the possible underlying mechanisms of
coronary artery spasm has prompted the use ofvarious 'provoca-
tive tests'. Much discussion has also centred around the argu-
ment that these tests may not be truly representative of the
operational mechanism in the patient subjected to the provoca-
tion. The 'cold pressor test' has been utilized for some years
now, the rationale for its use being the resulting sympathetic
stimulation with predominant a-adrenergic action. 26 Thus, an
increase in coronary resistance occurs, accompanied by a reduc-
tion in coronary blood flow in arteries affected by atherosclerotic
obstruction. On occasion this stimulus has proved so potent that
actual myocardial infarction has resulted. 27 However, general-
ized rather than focal vasoconstriction ensues, making it a some-
what unreliable provocative test. The 'hyperventilation test' has
also been employed, either alone or in combination with the
former test, with varying reliability.2 Thus, these stimuli have
mostly been abandoned in favour of the use of the 'ergonovine
stimulation test' .29-31 Ergonovine maleate has been shown to be
highly specific and sensitive in patients with Prinzmetal's variant
angina, and has therefore become the standard test for the provo-
cation of coronary vasospasm. Its safety has been firmly estab-
lished, although (rarely) complications such as ventricular fibril-
lation, complete heart block, AMI and death have been docu-
mented, especially when the test was not carried out with all the
caution required. Some centres use this provocation test on
outpatients,32 relying on the patient developing chest pain
accompanied by ST-segment elevation or depression, or even
pseudonormalization of T waves, for 'positivity'. However,
Conti er al. 4 are strict in their definition of a positive ergonovine
test, insisting on 'any reduction in coronary artery lumen, with or
without chest pain, accompanied by objective parameters of
myocardial ischaemia, in the absence of increased heart rate and
markedly increased blood pressure'. They therefore imply that
selective coronary angiography is mandatory in the performance
oftills provocative procedure. The diagnostic test has become so
reliable that workers are employing it in the assessment of the
effectiveness of medical therapy. Provoked coronary vasospasm
can usually be rapidly relieved by isosorbide dinitrate given
sublingually, or nitroglycerine injected either intravenously or
directly into the affected coronary artery.33 Very recently, sub-
lingual nifedipine has been successfully employed for this
purpose. 34
The coronary vasospasm - myocardial
infarction link
Oliva and Breckenridge3were the first to convincingly demon-
strate the importance ofcoronary artery vasospasm in the causa-
tion of AMI. These workers documented dilatation of a signifi-
cant coronary lesion in response to intracoronary nitroglycerine
in 40% of 15 patients who were catheterized within 12 hours of
having suffered an AMI. Furthermore, the fact that obstructive
coronary thrombi are absent in some 73 - 100% of patients dying
from non-transmural AMI, and in some 46% dying from trans-
mural AMI, makes the (likely) role of coronary vasospasm more
attractive. In fact, many researchers firmly believe that coronary
thrombosis only occurs subsequent to the onset of AMI.
The incrimination of coronary vasospasm as the initiating
factor in the development of AMI is strengthened by the know-
ledge that 15 - 20% of patients suffering from Prinzmetal's
variant angina sustain both non-transmural and transmural
myocardial infarctions. Maseri er al. 35 have demonstrated AMI
in the same area in which transient reversible ischaemia (attri-
buted to coronary artery spasm) had been noted on thallium-20 I
scintigrams. It is believed that most episodes'of coronary artery
spasm are too shortlived to result in myocardial infarction,
although the late intracoronary injection of nitrates may fail to
reverse the spasm. Gersh er at. 36 reported that vasospasm of
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angiographically normal coronary arteries might cause transmu-
ral AMI on an 'allergic' basis since one of their patients had
asthma, hypereosinophilia and systemic disease, probably of
immunological aetiology. This concept appears to be further
supported by the recent documentation ofcoronary artery spasm
as part ofan anaphylactoid reaction to iodine-containing contrast
material. 37
An exceptionally fine study by Gertz er al. 38 demonstrated the
production of coronary artery endothelial cell damage with sub-
sequent thrombus formation after partial experimental coronary
constriction, claiming that vasospasm was important in the cau-
sation of AMI. Recently Waters er al. 39 reported on the frequent
appearance of AMI within I month of the demonstration of
variant angina, and noted that this would take place in the
absence of significant fLxed atherosclerotic coronary lesions and
despite the apparent improvement of symptoms after adminis-
tration of calcium blockers. The real possibility that coronary
vasospasm could cause an extension of an AMI was recently
documented by Koiwaya er al. 40 These authors showed that
ST-segment elevation frequently occurred in areas represented
by new Q waves and in patients in whom the anatomical supply
was confirmed by angiographically documented and provoked
coronary vasospasm, and that life-threatening arrhythmias
ensued.
With the tremendous enthusiasm di played in attempt to
reduce infarct size by acute intracoronary thrombolysis with
streptokinase, the incidence of coronary vasospasm has been
estimated.. In a series of 30 patients, Lei"nbach and 'Gold41
showed that the main pathogenetic mechanism was that ofcoro-
nary thrombosis rather than coronary vasospasm. However,
more experience will be needed to determine the true incidence
of coronary vasospasm before, during, and after an AMI.
As regards the present case, there appear to be sufficient data
to suggest that previous transmural anteroseptal and non-
transmural anterolateral myocardial infarctions were due to
vasospasm of the LCA, since this was found to be patent on two
separate cardiac catheterization procedures. Also, coronary
vasospasm was clearly provoked in the RCA in the absence of an
inferior myocardial infarction. Thus, multiple coronary artery
spasm almost certainly took place. In addition, the frequent
episodes.of 'lOrsade de poinres' were more than likely secondary to
AMI precipitated by significant coronary artery spasm.
Therapeutic considerations
The most effective drugs for coronary vasospasm appear to be
either the long-acting nitrates42 or calcium-channel blockers,43
or a combination of these two, although some authors have
reported improvement in only 50% of patients treated with long-
acting nitrates, perhaps because of the short pharmacological
half-life of these drugs. Nevertheless, nitroglycerine ointment
has proved most efficacious in the coronary care unit,44 and will
probably be used more extensively in the future. The various
calcium-blocking drugs, such as nifedipine,45 diltiazem,46 vera-
pamil47 and amiodarone48 have also been used with exceptionally
good results and would certainly seem to offer the most ideal
form of medical therapy to date.
A surgical approach to therapy consists ofplexectomy (partial
denervation of the heart), combined with coronary artery bypass
if haemodynamically significant atherosclerotic obstructive
lesions are also present.49 A more drastic form of surgery is that
of complete denervation of the heart (autotransplantation),
which has been employed successfully in severe refractory coro-
nary' vasospasm.50 The effectiveness or otherwise of treatment
has been assessed by the use of repeat ergonovine provocation
tests, as well as hyperventilation in some patients.
On theoretical grounds the use ofR-adrenergic blocking drugs
would be contraindicated in proved coronary vasospasm because
they unmask the a-adrenergic action stimulated by endogenous
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clltecholamines. Worsening of variant angina has been clearly
docume.nted,51 and these drugs should therefore be employed
only as a last resort. However, the use of selective B,-receptor
blockade should lessen this adverse action.
So far, the therapeutic response ofmy patient is most satisfac-
tory. He has denied any further rest- or effort-related angina,
and has had no more episodes of presyncope or syncope.
Repeated Holter monitoring has failed to detect any ectopic
ventricular activity, specifically episodes of 'corsade de poinces'.
I wish to sincerely thank Miss H. Weymar ofthe Cardiology Unit,
Tygerberg Hospital, for preparing the manuscript. Thanks are also
d\J.e to. Mr Chris Wilberforce, Head of the Department of Photo-
graphy, for his painstaking preparation of the photographs. Finally,
due acknowledgement is made to Dr C. Vivier, ChiefMedical Super-
intendent of Tygerberg Hospital,-for permission to publish.
REFERENCES
I. Prinzmetal M, Kennamer R, Merliss R et al. A variant form ofangina pectoris;
preliminary report. Am] Med 1959; 27: 375-388.
2. MacAlpin RN. Relation of coronary arterial spasm to sites oforganic stenosis.
Am] Cardiol1980; 46: 143-153.
3. Oliva PB, Breckenridge Je. Acme myocardial infarction with normal and near
normal coronary arteries. Documentation "rith coronary arteriography \\rithin
121/, hours of the onset ofsymptoms in tvmcases (threeepisodes).Am]Cardiol
1977; 40: 1000-1007.
4. Conti CR, Feldman RL, Pepine CJ. Coronary artery spasm; prevalence, clini-
cal significance, and provocative testing. Am HeaT!] 1982; 103: 584-588.
5. Chabine RA, Raizner AE, Ishimori T, Luchi RJ, McIntosh HD. Tbe incidence
and clinical implications of coronary artery spasm. Circularion 1975; 52:
972-978.
6. Maseri A, Chierchia S, I: Abbate A. Pathogenetic meehanisms underlying the
clinical events associated with atherosclerotic heart disease. Circulation 1980;
62: supp V, 3-13.
7. Dessertenne F. La tachycardie venrriculaire adeux foyers opposes variables..
Arch Mal Coeur 1966; 59: 263. .
8. Meltzer RS, Robert EW, McMorrow M er al. Atypical ventricular tachycardia
as a manif~tation ofdisopyramide toxicity. Am] Cardioll978; 42: 1049-1053.
9. Smirk FH, Ng J. Cardiac ballet: repetitions of complex eleerrocardiographic
_ pairems. Br HeaT!] 1969; 31: 426-434.
10. Tamura K, Tamura T, Yoshida S, Inui M, Fukuhara N. Transient recurrent
venrricular fibrillation due to hypopotassemia with special note on the 0 wave.
]pn Heart] 1967;·8: 652.
11. Krikler DM. A fresh look at cardiac arrhythmias. Lancet 1974; i: 913-918.
12. Krikler DM, Curry. PVL. Torsade de poinres, an atypical ventricular tachycar-
dia (Editorial). Br Hearr] 1976; 38: 117-120.
13. Seltzer A, Wray HW. Quinidine syncope. Paroxysmal ventricular fibrillation
1lCCurring during rrearment ofchronic atrial arrhythmias. Circulation 1964; 30:
17-26.
14. Nicholson WJ, Martin CE, Gracey JG, Knoch HR. Disopyramide-induced
ventricular fibrillation. Am] Cardiol 1979; 43: 1053-1055.
15. Keren A, J"zivoni D, Gottlieb S, Benhorin J, Stem S. Atypical ventricular
tachycardia (torsade de poinres) induced by amiodarone. CheSl 1982; 81:
384-386.
16. Schoonmaker FW, Osteen RT, Greenfield JC. Thioridazine (Mellaril) induced
ventricular tachycardia controlled with an artificial pacemaker. Ann Intern Med
1966; 65: 1076-1078.
17. Chiche P, Haiat R, Steff P. Angina pectoris with syncope due to paroxysmal
atrioventricular block: role of ischaemia. Report of two cases. Br Heart] 1974;
36: 577-581.
18. Parodi 0, Uthurralt N, Severi S er al. Transient reduction of regional myocar-
dial perfuslon during angina at rest with ST-segment depression or normaliza-
tion of negative T waves. Circulation 1981; 63: 1238-1247.
19. Chaitman BR, Waters DD, Tberoux P, Hanson JS. S-Tsegment elevation and
coronary artery spasm in response to exercise. Am] Cardiol 1981; 47:
1350-1358.
20. Waters DD, Chaitman BR, Dupras G, Theroux P, Mizgala HF. Coronary
artery spasm during exercise in patients with variant angina. Circulation 1979;
59: 580-585.
21. Boden WE, Bough EW, Korr KS et al. Exercise-induced coronary artery
spasm with S-T segment depression and normal coronary arteriography. Am]
Cardiol1981; 48: 193-197.
22. Dunn RF, Kelly DT, Sadick N, Oren R. Multivessel coronary artery spasm.
Circularion 1979; 60: 451-455.
23. Yasue H. Pathophysiology and treatment of coronary ~ teria! spasm. Chesr
1980; 78: 216-223.
24. Ginsburg R, Bristow MR, Harrison DC, Stinson EB. Studies with isolated
human coronary arteries: some general observations, potential mediators of
spasm, role of calcium antagonists. Chesr 1980; 78: 180-186.
25. Bristow MR, Ginsburg R, Harrison De. Histamine and the heart; the other
reeeptor system. Am] Cardiol)982; 49: 249-251.
26. Raizner AE, Chahme RA, Ishimori T er al. Provocation of coronary artery
spasm by the cold pressor test· haemodynamic, arteriographic and quantitative
angiographic observations. Circularion 1980; 62: 925-932.
27. Shea DJ, Ockene IS, Greene HL. Acute myocardial infarction provoked by a
cold pressor test. Chest 1981; 80: 649-651.
28. Gironi LA, Crosano JR, Messuti H et al. The hyperventilation test as a
method for developing successful therapy in Prinzmetal's angina. Am] Cardiol
1982; 49: 834-841.
29. Heupler FA, Proudfit WL, Razavi M, Shirey EK, Greenstreet R, Shddon
We. Ergonovine maleate provocative test for coronary arterial spasm. Am]
Cardio/1978; 41: 631-640. .~
30. HeupIer FA. Provocative testing for coronary arterial spasm: risk, method and
rationale. Am] Cardiol 1980; 46: 335-337.
31. Waters DD, Tberoux P, Szlachic J et al. Ergonovine testing in a coronary care
unit. Am] Cardiol 1980; 46: 922-930.
32. Ginsburg R, Lamb IH, Bristow MR, Schroeder JS, Harrison De. Application
and safety of outpatient ergonovine testing in accurately detecting coronary
spasm in patients with possible variant angina. Am Heart] 1981; 102: 698-702.
33. Pepine CJ, Feldman RL, Conti CR. Action of intracoronary nitroglycerine in
refractory coronary artery spasm. Circularion 1982; 65: 411-414.
34. Schwartz T, Halon D, Gotsman MS. Angiographic relief of coronary artery
spasm with sublingual nifedipine. Chesr 1982; 81: 127-128.
35. Maseri A, L'Abbate A, Baroldi G er al. Coronary vasospasm as a possible cause
of myocardial infarction. In: Mason DT, Neri Semeri GG, Oliver MF, eds.
Internarional Meeting on Myocardial Infarction (International Congress Series
No. 491). Amsterdam: Excerpta Medica, 1979: 67-74.
36. Gersh BJ, Bassendine MF, Forman R, Walls RS, Beck W. Coronary artery
spasm and myocardial infarction in the absence of angiographically demon-
strable obstructive coronary disease. Mayo Clin Proc 1981; 56: 700-708.
37. Druck MN, Johnstone DE, Staniloff H, McLaughlin PR. Coronary artery
spasm as a manifestation of anaphylactoid reaction to iodinated contrast mate-
rial. Can Med Assoc] 1981; 125: 1133-1135.
38. Gertz SD, UretskyG, WajnbergRS, Navot N, Gotsman MS. Endothelial cell
damage and thrombus formation after partial arterial constriction: relevance to
the role ofcoronary artery spasm in the pathogenesis of myocardial infarction.
Circulation 1981; 63: 476-486.
39. Waters DD, Szlachicic J, Miller D, Tberoux P. Clinical characteristics of
patients with variant angina complicated by myocardial infarction death within
I month. Am] Cardiol 1982; 49: 658-664.
40. Koiwaya Y, Torii S, Takeshita A, Nakagaki 0, Nakarnura M. Post-infarction
angina caused by coronary arterial spasm. Circulation 1982; 65: 275-280.
41. Leinbach RC, Gold HK. Coronary angiography during acute myocardial
infarction: a search for spasm. Am Heart] 1982; 103: 768-772.
42. Ginsburg R, Lamb IH, Schroeder JS, Hu M, Harrison De.Randomized
double-blind comparison of nifedipine and isosorbide dinirrate theraJlY in
variant angina pectoris due to coronary artery spasm. Am Heart] 1982; 103:
44-48.
43. Gunther S, Muller JE, Mudge GH, Grossman W. Therapy of coronary
vasoconstriction in patients with coronary artery disease. Am] Cardio/l98l;
47: 157-162.
44. Saleroo JA, Previtali M, Medici A et al. Treatment of vasospastic angina
pectoris at rest with nirroglycerine ointment: a short-term controlled study in
the coronary care unit. Am] Cardio/1981; 47: 1128-1133.
45. Hill JA, Feldman RL, Pepine Cl, Conti CR. Randomized double-blind com-
parison ofnifedipine and isosorbide dinirrate in patients with coronary arterial
spasm. Am] Cardio11982; 49: 431-438.
46. Kimura E, Kishida H. Treatment of variant angina with drugs: a survey of II
cardiology institutes in Japan. Circularion; 1981; 63: 844-848.
47. Johnson SM, Mauritson DR, Willerson JT, Cary JR, Hillis D. Verapamil
administration in variant angina pectoris: efficacy shown by ECG monitoring.
]AMA 1981; 245: 1849-1851.
48. Rutitzky B, Girotti AL, Rosenbaum MB. Efficacy of chronic amiodarone
therapy in patients with variant angina pectoris and inhibition of ergonovine
coronary constriction. Am Heart] 1982; 103: 38-43.
49. Bertrand ME, Lablanche JM, Tilmant PY. Treatment of Prinzmetal's variant
angina: role of medical rreatment with nifedipine and surgical coronary revas-
cularization combined with plexectomy. Am] Cardio/l98l; 47: 174-178.
50. Bertrand ME, Lablanche JM, Tilmant PY, Ducloux G, Warembourg H, Soots
G. Complete denervation of the heart (autotransplantation) for trearment of
severe, refractory coronary spasm. Am] Cardiol 1981; 47: 1375-1378.
51. Roberrson RM, Wood AJJ, Vaughn WK, Robertson D. Exacerbation of
vasotonic angina pectoris by propranolol. Circularion 1982; 65: 281-285.
